Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats.

Wimalawansa SJ, Chapa MT, Yallampalli C, Zhang R, Simmons DJ.

Bone. 1997 Sep;21(3):275-80.

PMID:
9276093
2.

Nitric oxide donor alleviates ovariectomy-induced bone loss.

Wimalawansa SJ, De Marco G, Gangula P, Yallampalli C.

Bone. 1996 Apr;18(4):301-4.

PMID:
8726385
3.

Prevention of corticosteroid-induced bone loss with alendronate.

Wimalawansa SJ, Simmons DJ.

Proc Soc Exp Biol Med. 1998 Feb;217(2):162-7.

PMID:
9452139
4.

Supplementation of L-arginine prevents glucocorticoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model.

Pennisi P, D'Alcamo MA, Leonetti C, Clementi A, Cutuli VM, Riccobene S, Parisi N, Fiore CE.

J Bone Miner Metab. 2005;23(2):134-9.

PMID:
15750691
5.

Frequency-dependent effect of nitric oxide donor nitroglycerin on bone.

Wimalawansa S, Chapa T, Fang L, Yallampalli C, Simmons D, Wimalawansa S.

J Bone Miner Res. 2000 Jun;15(6):1119-25.

6.

Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia.

Hukkanen M, Platts LA, Lawes T, Girgis SI, Konttinen YT, Goodship AE, MacIntyre I, Polak JM.

Bone. 2003 Feb;32(2):142-9.

PMID:
12633786
7.

Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats.

Ke HZ, Crawford DT, Qi H, Pirie CM, Simmons HA, Chidsey-Frink KL, Chen HK, Jee WS, Thompson DD.

Bone. 1999 Jan;24(1):41-7.

PMID:
9916783
8.
9.

Restoration of ovariectomy-induced osteopenia by nitroglycerin.

Wimalawansa SJ.

Calcif Tissue Int. 2000 Jan;66(1):56-60.

PMID:
10602846
10.

The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica.

Pearce G, Ryan PF, Delmas PD, Tabensky DA, Seeman E.

Br J Rheumatol. 1998 Mar;37(3):292-9.

PMID:
9566670
11.
12.
13.

The effects of nandrolone decanoate on bone mass and metabolism in ovariectomized rats with osteopenia.

Li X, Takahashi M, Kushida K, Shimizu S, Hoshino H, Suzuki M, Inoue T.

J Bone Miner Metab. 2000;18(5):258-63.

PMID:
10959614
14.

Effects of tibolone (Org OD14) treatment for 3 months on ovariectomy-induced osteopenia in 8-month-old rats on a low-calcium diet: preventive testing for 3 months.

Kasugai Y, Ikegami A, Matsuo K, Ohashi M, Sukamoto T, Hosoi T, Ouchi Y, Orimo H.

Bone. 1998 Feb;22(2):119-24.

PMID:
9477234
16.

Effect of etidronate on bone in orchidectomized and sciatic neurectomized adult rats.

Iwamoto J, Takeda T, Katsumata T, Tanaka T, Ichimura S, Toyama Y.

Bone. 2002 Feb;30(2):360-7.

PMID:
11856643
17.

L-arginine prevents bone loss and bone collagen breakdown in cyclosporin A-treated rats.

Fiore CE, Pennisi P, Cutuli VM, Prato A, Messina R, Clementi G.

Eur J Pharmacol. 2000 Nov 24;408(3):323-6.

PMID:
11090650
18.

Bone mineral density and biomechanical properties of spine and femur of ovariectomized rats treated with naproxen.

Jiang Y, Zhao J, Genant HK, Dequeker J, Geusens P.

Bone. 1998 May;22(5):509-14.

PMID:
9600785
19.

Effect of zinc supplementation on bone metabolism in male rats chronically exposed to cadmium.

Brzóska MM, Rogalska J, Galazyn-Sidorczuk M, Jurczuk M, Roszczenko A, Kulikowska-Karpińska E, Moniuszko-Jakoniuk J.

Toxicology. 2007 Jul 31;237(1-3):89-103. Epub 2007 May 5.

PMID:
17560002

Supplemental Content

Support Center